We are live on
!
Find out more
BBA
BLB&B Advisors Portfolio holdings
AUM
$2.73B
Turnover
8.25%
1-Year Est. Return
25.76%
This Fund
S&P 500
This Quarter
Est. Return
+13.11%
1 Year Est. Return
+25.76%
3 Year Est. Return
+71.58%
5 Year Est. Return
+74.54%
10 Year Est. Return
+243.21%
AUM
$850M
AUM Growth
+$122M
(+17%)
Cap. Flow
+$31.1M
Cap. Flow
% of AUM
3.65%
Top 10 Holdings %
Top 10 Hldgs %
30.1%
Holding
286
New
14
Increased
81
Reduced
142
Closed
9
Avg Time Held
4.1
years
Top 10 Avg Time Held
2.6
years
Top 20 Avg Time Held
3.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
LPT
Liberty Property Trust
LPT
|
+$7.12M |
| 2 |
Schwab US Mid-Cap ETF
SCHM
|
+$5.28M |
| 3 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$5.02M |
| 4 |
iShares Core S&P Small-Cap ETF
IJR
|
+$4.82M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$3.39M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ionis Pharmaceuticals
IONS
|
+$4.05M |
| 2 |
The Kraft Heinz Company
KHC
|
+$1.54M |
| 3 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$998K |
| 4 |
Kimberly-Clark
KMB
|
+$845K |
| 5 |
Cisco
CSCO
|
+$825K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 35.15% |
| 2 | Technology | 12.88% |
| 3 | Healthcare | 11.72% |
| 4 | Industrials | 7.63% |
| 5 | Financials | 7.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
176
Xerox
XRX
$352M
| $593K | 0.07% |
18,551
-250
| -1% | -$7.05K |
2013 Q2
23 quarters
|
|
177
RTX Corp
RTX
$252B
| $586K | 0.07% |
7,219
+636
| +10% | +$48.3K |
2013 Q2
23 quarters
|
|
178
Bank of New York Mellon
BNY
$96.4B
| $575K | 0.07% |
11,405
-918
| -7% | -$47.3K |
2013 Q2
23 quarters
|
|
179
Invesco Pennsylvania Value Municipal Income Trust
VPV
$196M
| $545K | 0.06% |
43,738
+2,402
| +6% | +$29.2K |
2013 Q2
23 quarters
|
|
180
McDonald's
MCD
$172B
| $539K | 0.06% |
2,840
+250
| +10% | +$45.4K |
2017 Q2
7 quarters
|
|
181
Hershey
HSY
$33.9B
| $538K | 0.06% |
4,685
-600
| -11% | -$65.3K |
2013 Q4
21 quarters
|
|
182
DELISTED
Unilever NV New York Registry Shares
UN
| $525K | 0.06% |
9,005
| – | – |
2014 Q1
20 quarters
|
|
|
RDS.B
183
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $516K | 0.06% |
8,067
-5,400
| -40% | -$341K |
2015 Q3
14 quarters
|
|
184
Goldman Sachs ActiveBeta International Equity ETF
GSIE
$5.92B
| $501K | 0.06% |
17,861
| – | – |
2016 Q3
10 quarters
|
|
185
iShares National Muni Bond ETF
MUB
$49.2B
| $500K | 0.06% |
4,500
| – | – |
2016 Q1
12 quarters
|
|
186
Vodafone
VOD
$36.7B
| $468K | 0.06% |
25,759
-2,290
| -8% | -$42.5K |
2013 Q2
23 quarters
|
|
187
Teleflex
TFX
$5.43B
| $456K | 0.05% |
1,508
-50
| -3% | -$13.9K |
2015 Q2
15 quarters
|
|
188
Vanguard S&P 500 ETF
VOO
$1.05T
| $454K | 0.05% |
1,750
| – | – |
2014 Q1
20 quarters
|
|
189
Public Service Enterprise Group
PEG
$35B
| $447K | 0.05% |
7,519
-595
| -7% | -$33.3K |
2013 Q4
21 quarters
|
|
190
VanEck IG Floating Rate ETF
FLTR
$3.48B
| $433K | 0.05% |
17,195
-22,833
| -57% | -$571K |
2018 Q3
2 quarters
|
|
191
Nutrien
NTR
$33.2B
| $429K | 0.05% |
8,128
+438
| +6% | +$22.8K |
2018 Q1
4 quarters
|
|
192
Novartis
NVS
$286B
| $422K | 0.05% |
4,899
-360
| -7% | -$28.9K |
2013 Q2
23 quarters
|
|
193
Atmos Energy
ATO
$27.7B
| $408K | 0.05% |
3,965
| – | – |
2014 Q2
19 quarters
|
|
194
Norfolk Southern
NSC
$73B
| $407K | 0.05% |
2,180
-500
| -19% | -$86.5K |
2016 Q2
11 quarters
|
|
195
DELISTED
iShares Frontier and Select EM ETF
FM
| $406K | 0.05% |
14,265
-2,260
| -14% | -$63.8K |
2014 Q1
20 quarters
|
|
196
Philip Morris
PM
$312B
| $396K | 0.05% |
4,485
-1,640
| -27% | -$132K |
2013 Q2
23 quarters
|
|
197
DELISTED
Paramount Global Class B
PARA
| $388K | 0.05% |
8,161
-336
| -4% | -$16.4K |
2013 Q2
23 quarters
|
|
198
General Mills
GIS
$17.6B
| $386K | 0.05% |
7,462
-1,000
| -12% | -$45.3K |
2014 Q2
19 quarters
|
|
199
Oracle
ORCL
$408B
| $382K | 0.04% |
7,105
-500
| -7% | -$25.5K |
2013 Q2
23 quarters
|
|
200
Liberty All-Star Equity Fund
USA
$1.84B
| $382K | 0.04% |
62,440
+2,055
| +3% | +$12.1K |
2017 Q3
6 quarters
|
|
Similar funds
MAS
ACM
CIAS
LIM
SIG
AGA
GXJ
TAM
BLB&B Advisors's Q1 2019 Portfolio in Review
As of Q1 2019, BLB&B Advisors held 286 positions worth $850M, up 17% from $728M the previous quarter. Its ten largest holdings account for 30% of the portfolio.
BLB&B Advisors deployed $31.1M of net new capital in Q1 2019, opening 14 new positions and adding to 81 existing holdings. Its largest new stake was Liberty Property Trust: 152,971 shares worth $7.41M.
By sector, the portfolio is most concentrated in Miscellaneous at 35% of assets, up from 34% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Ionis Pharmaceuticals, an estimated $4.05M trimmed.
- BLB&B Advisors's largest Q1 2019 buy was Liberty Property Trust: 152,971 shares worth $7.41M.
- BLB&B Advisors added most to Schwab US Mid-Cap ETF in Q1 2019, an estimated $5.28M increase.
- BLB&B Advisors's biggest Q1 2019 reduction was Ionis Pharmaceuticals, cutting an estimated $4.05M.
- BLB&B Advisors fully exited Biogen in Q1 2019, selling an estimated $360K.
- BLB&B Advisors's ten largest holdings make up 30% of its $850M portfolio in Q1 2019.
- BLB&B Advisors opened 14 new positions and closed 9 in Q1 2019.
- BLB&B Advisors's portfolio value rose 17% quarter-over-quarter to $850M.
Based on BLB&B Advisors's 13F filing for Q1 2019, filed 19 Apr 2019.